HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repression of protein translation and mTOR signaling by proteasome inhibitor in colon cancer cells.

Abstract
Protein homeostasis relies on a balance between protein synthesis and protein degradation. The ubiquitin-proteasome system is a major catabolic pathway for protein degradation. In this respect, proteasome inhibition has been used therapeutically for the treatment of cancer. Whether inhibition of protein degradation by proteasome inhibitor can repress protein translation via a negative feedback mechanism, however, is unknown. In this study, proteasome inhibitor MG-132 lowered the proliferation of colon cancer cells HT-29 and SW1116. In this connection, MG-132 reduced the phosphorylation of mammalian target of rapamycin (mTOR) at Ser2448 and Ser2481 and the phosphorylation of its downstream targets 4E-BP1 and p70/p85 S6 kinases. Further analysis revealed that MG-132 inhibited protein translation as evidenced by the reductions of (35)S-methionine incorporation and polysomes/80S ratio. Knockdown of raptor, a structural component of mTOR complex 1, mimicked the anti-proliferative effect of MG-132. To conclude, we demonstrate that the inhibition of protein degradation by proteasome inhibitor represses mTOR signaling and protein translation in colon cancer cells.
AuthorsWilliam Ka Kei Wu, Viviana Volta, Chi Hin Cho, Ya Chun Wu, Hai Tao Li, Le Yu, Zhi Jie Li, Joseph Jao Yiu Sung
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 386 Issue 4 Pg. 598-601 (Sep 04 2009) ISSN: 1090-2104 [Electronic] United States
PMID19540199 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents
  • Cysteine Proteinase Inhibitors
  • Leupeptins
  • Proteasome Inhibitors
  • Protein Synthesis Inhibitors
  • Proteins
  • RPTOR protein, human
  • Regulatory-Associated Protein of mTOR
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Topics
  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents (pharmacology)
  • Colonic Neoplasms (enzymology)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • Humans
  • Leupeptins (pharmacology)
  • Phosphorylation (drug effects)
  • Polyribosomes (drug effects, metabolism)
  • Proteasome Inhibitors
  • Protein Biosynthesis (drug effects)
  • Protein Kinases (metabolism)
  • Protein Synthesis Inhibitors (pharmacology)
  • Proteins (genetics)
  • Regulatory-Associated Protein of mTOR
  • TOR Serine-Threonine Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: